Trial Outcomes & Findings for Aligning Pulse Oximetry With Guidelines (NCT NCT04178941)
NCT ID: NCT04178941
Last Updated: 2023-09-08
Results Overview
The participant rates the feasibility of the intervention based on this statement: "Data feedback about our use of continuous pulse oximetry in patients with bronchiolitis is easy to implement." Data was only collected from the "STAFF SURVEYED - Intervention (Single Arm)" Arm/Group for this Outcome Measure.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
1898 participants
Primary outcome timeframe
1 month after intervention
Results posted on
2023-09-08
Participant Flow
Participant milestones
| Measure |
PATIENTS OBSERVED - Intervention (Single Arm)
This arm refers to patients who were exposed to the intervention described below and who had their clinical data collected prospectively during the trial.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
STAFF SURVEYED - Intervention (Single Arm)
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
|---|---|---|
|
Overall Study
STARTED
|
1051
|
847
|
|
Overall Study
COMPLETED
|
1051
|
847
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
1049/1051 patients had sex data available in the medical record 818/847 survey respondents chose to disclose their sex
Baseline characteristics by cohort
| Measure |
PATIENTS OBSERVED - Intervention (Single Arm)
n=1051 Participants
This arm refers to patients who were exposed to the intervention described below and who had their clinical data collected prospectively during the trial.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
STAFF SURVEYED - Intervention (Single Arm)
n=847 Participants
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
Total
n=1898 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
Age category · 8 weeks - 5 months old
|
534 Participants
n=1051 Participants
|
0 Participants
n=847 Participants
|
534 Participants
n=1898 Participants
|
|
Age, Customized
Age category · 6 months - 11 months old
|
284 Participants
n=1051 Participants
|
0 Participants
n=847 Participants
|
284 Participants
n=1898 Participants
|
|
Age, Customized
Age category · 12 months - 17 months old
|
153 Participants
n=1051 Participants
|
0 Participants
n=847 Participants
|
153 Participants
n=1898 Participants
|
|
Age, Customized
Age category · 18 months - 23 months old
|
80 Participants
n=1051 Participants
|
0 Participants
n=847 Participants
|
80 Participants
n=1898 Participants
|
|
Age, Customized
Age category · Unknown age
|
0 Participants
n=1051 Participants
|
847 Participants
n=847 Participants
|
847 Participants
n=1898 Participants
|
|
Sex: Female, Male
Female
|
438 Participants
n=1049 Participants • 1049/1051 patients had sex data available in the medical record 818/847 survey respondents chose to disclose their sex
|
695 Participants
n=818 Participants • 1049/1051 patients had sex data available in the medical record 818/847 survey respondents chose to disclose their sex
|
1133 Participants
n=1867 Participants • 1049/1051 patients had sex data available in the medical record 818/847 survey respondents chose to disclose their sex
|
|
Sex: Female, Male
Male
|
611 Participants
n=1049 Participants • 1049/1051 patients had sex data available in the medical record 818/847 survey respondents chose to disclose their sex
|
123 Participants
n=818 Participants • 1049/1051 patients had sex data available in the medical record 818/847 survey respondents chose to disclose their sex
|
734 Participants
n=1867 Participants • 1049/1051 patients had sex data available in the medical record 818/847 survey respondents chose to disclose their sex
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
305 Participants
n=1051 Participants
|
77 Participants
n=847 Participants
|
382 Participants
n=1898 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
609 Participants
n=1051 Participants
|
703 Participants
n=847 Participants
|
1312 Participants
n=1898 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
137 Participants
n=1051 Participants
|
67 Participants
n=847 Participants
|
204 Participants
n=1898 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=1051 Participants
|
4 Participants
n=847 Participants
|
5 Participants
n=1898 Participants
|
|
Race (NIH/OMB)
Asian
|
38 Participants
n=1051 Participants
|
161 Participants
n=847 Participants
|
199 Participants
n=1898 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
5 Participants
n=1051 Participants
|
9 Participants
n=847 Participants
|
14 Participants
n=1898 Participants
|
|
Race (NIH/OMB)
Black or African American
|
236 Participants
n=1051 Participants
|
26 Participants
n=847 Participants
|
262 Participants
n=1898 Participants
|
|
Race (NIH/OMB)
White
|
354 Participants
n=1051 Participants
|
515 Participants
n=847 Participants
|
869 Participants
n=1898 Participants
|
|
Race (NIH/OMB)
More than one race
|
15 Participants
n=1051 Participants
|
30 Participants
n=847 Participants
|
45 Participants
n=1898 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
402 Participants
n=1051 Participants
|
102 Participants
n=847 Participants
|
504 Participants
n=1898 Participants
|
PRIMARY outcome
Timeframe: 1 month after interventionPopulation: 659 of the 847 overall respondents to the survey responded to this question.
The participant rates the feasibility of the intervention based on this statement: "Data feedback about our use of continuous pulse oximetry in patients with bronchiolitis is easy to implement." Data was only collected from the "STAFF SURVEYED - Intervention (Single Arm)" Arm/Group for this Outcome Measure.
Outcome measures
| Measure |
STAFF SURVEYED - Intervention (Single Arm)
n=659 Participants
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
|---|---|
|
Audit & Feedback Feasibility Using Adapted Item From Feasibility of Intervention Measure (FIM)
Completely agree
|
222 Participants
|
|
Audit & Feedback Feasibility Using Adapted Item From Feasibility of Intervention Measure (FIM)
Agree
|
331 Participants
|
|
Audit & Feedback Feasibility Using Adapted Item From Feasibility of Intervention Measure (FIM)
Neither agree nor disagree
|
86 Participants
|
|
Audit & Feedback Feasibility Using Adapted Item From Feasibility of Intervention Measure (FIM)
Disagree
|
20 Participants
|
|
Audit & Feedback Feasibility Using Adapted Item From Feasibility of Intervention Measure (FIM)
Completely diagree
|
0 Participants
|
PRIMARY outcome
Timeframe: 1 month after interventionPopulation: 659/847 survey respondents answered this question.
The participant rates the acceptability of the intervention based on this statement: "I like the data feedback." Data was only collected from the "STAFF SURVEYED - Intervention (Single Arm)" Arm/Group for this Outcome Measure.
Outcome measures
| Measure |
STAFF SURVEYED - Intervention (Single Arm)
n=659 Participants
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
|---|---|
|
Audit & Feedback Acceptability Using Adapted Item From Acceptability of Intervention Measure (FIM)
Completely agree
|
305 Participants
|
|
Audit & Feedback Acceptability Using Adapted Item From Acceptability of Intervention Measure (FIM)
Agree
|
305 Participants
|
|
Audit & Feedback Acceptability Using Adapted Item From Acceptability of Intervention Measure (FIM)
Neither agree nor disagree
|
46 Participants
|
|
Audit & Feedback Acceptability Using Adapted Item From Acceptability of Intervention Measure (FIM)
Disagree
|
2 Participants
|
|
Audit & Feedback Acceptability Using Adapted Item From Acceptability of Intervention Measure (FIM)
Completely disagree
|
1 Participants
|
PRIMARY outcome
Timeframe: 1 month after interventionPopulation: 659/847 survey respondents answered this question.
The participant rates the appropriateness of the intervention based on this statement: "Data feedback about our use of continuous pulse oximetry in bronchiolitis seems like a good match for our non-ICU floors that care for bronchiolitis." Data was only collected from the "STAFF SURVEYED - Intervention (Single Arm)" Arm/Group for this Outcome Measure.
Outcome measures
| Measure |
STAFF SURVEYED - Intervention (Single Arm)
n=659 Participants
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
|---|---|
|
Audit & Feedback Appropriateness Using Adapted Item From Intervention Appropriateness Measure (IAM)
Completely agree
|
280 Participants
|
|
Audit & Feedback Appropriateness Using Adapted Item From Intervention Appropriateness Measure (IAM)
Agree
|
337 Participants
|
|
Audit & Feedback Appropriateness Using Adapted Item From Intervention Appropriateness Measure (IAM)
Neither agree nor disagree
|
37 Participants
|
|
Audit & Feedback Appropriateness Using Adapted Item From Intervention Appropriateness Measure (IAM)
Disagree
|
4 Participants
|
|
Audit & Feedback Appropriateness Using Adapted Item From Intervention Appropriateness Measure (IAM)
Completely disagree
|
1 Participants
|
SECONDARY outcome
Timeframe: 4 monthsContinuous pulse oximetry use rates in children with bronchiolitis who are not requiring supplemental oxygen administration. This is calculated as the number of patients continuously monitored when not receiving supplemental oxygen divided by the total number of patients observed when not receiving supplemental oxygen.
Outcome measures
| Measure |
STAFF SURVEYED - Intervention (Single Arm)
n=1051 Participants
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
|---|---|
|
Hospital-level Percentage of Patients Continuously Monitored When Not Receiving Supplemental Oxygen
|
236 Participants
|
SECONDARY outcome
Timeframe: 4 monthsPopulation: The denominator of sensitivity is those patients who were truly monitored, which for this analysis was 102.
This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside). This outcome compared EHR data at minute 0 (same minute as direct observation occurred). The numerator is the number of patients with EHR data from the medical monitoring device. The denominator is the number of patients who were truly monitored.
Outcome measures
| Measure |
STAFF SURVEYED - Intervention (Single Arm)
n=102 Participants
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
|---|---|
|
Sensitivity of the Presence of Electronic Health Record (EHR) Data From the Medical Monitoring Device for Actual Monitoring at the Bedside in Bronchiolitis. Sensitivity is Also Referred to as the "True Positive Rate."
|
92 Participants
|
SECONDARY outcome
Timeframe: 4 monthsPopulation: The denominator for specificity in this analysis was the number of patients who were truly not monitored, which was 566 patients.
This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside). This outcome compared EHR data at minute 0 (same minute as direct observation occurred). The numerator is the number of patients with absence of EHR data from the medical monitoring device. The denominator is the number of patients who were truly not monitored.
Outcome measures
| Measure |
STAFF SURVEYED - Intervention (Single Arm)
n=566 Participants
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
|---|---|
|
Specificity of the Absence of Electronic Health Record Data From the Medical Monitoring Device for Absence of Monitoring at the Bedside in Bronchiolitis. Specificity is Also Referred to as the "True Negative Rate."
|
554 Participants
|
SECONDARY outcome
Timeframe: 4 monthsPopulation: The denominator for PPV calculation was the total number of patients who had EHR data suggesting that they were continuously monitored, which was 104 patients.
This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside). This outcome compared EHR data at minute 0 (same minute as direct observation occurred). The numerator is the number of patients who were continuously monitored at the bedside. The denominator is the number of patients who had EHR data suggesting that they were continuously monitored.
Outcome measures
| Measure |
STAFF SURVEYED - Intervention (Single Arm)
n=104 Participants
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
|---|---|
|
Positive Predictive Value (PPV) of the Presence of Electronic Health Record Data From the Medical Monitoring Device for Actual Monitoring at the Bedside in Bronchiolitis.
|
92 Participants
|
SECONDARY outcome
Timeframe: 4 monthsPopulation: The denominator for negative predictive value calculation was the total number of patients who had EHR data suggesting that they were NOT continuously monitored, which was 564 patients.
This measure will be calculated using chart review (to determine presence of electronic health record data from the medical monitoring device) and direct observation (to determine actual monitoring at the bedside). This outcome compared EHR data at minute 0 (same minute as direct observation occurred). The numerator is the number of patients who were not observed to be continuously monitored at the bedside. The denominator is the number of patients who had EHR data suggesting that they were NOT continuously monitored.
Outcome measures
| Measure |
STAFF SURVEYED - Intervention (Single Arm)
n=564 Participants
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
|---|---|
|
Negative Predictive Value of the Absence of Electronic Health Record Data From the Medical Monitoring Device for Absence of Monitoring at the Bedside in Bronchiolitis.
|
554 Participants
|
Adverse Events
PATIENTS OBSERVED - Intervention (Single Arm)
Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths
STAFF SURVEYED - Intervention (Single Arm)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
PATIENTS OBSERVED - Intervention (Single Arm)
n=1051 participants at risk
This arm refers to patients who were exposed to the intervention described below and who had their clinical data collected prospectively during the trial.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
STAFF SURVEYED - Intervention (Single Arm)
This arm refers to staff who were exposed to the intervention described below and who responded to the surveys administered for the feasibility, acceptability, and appropriateness outcome measures.
The intervention is a combined educational outreach and audit and feedback strategy that includes providing the hospital's own continuous pulse oximetry use data back to them on a weekly basis. The data will be accompanied by staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
Audit and Feedback: The audit and feedback intervention includes providing each hospital's own continuous pulse oximetry use data back to them on a weekly basis for review and action.
Educational outreach: Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for continuous pulse oximetry use in bronchiolitis.
|
|---|---|---|
|
Respiratory, thoracic and mediastinal disorders
a code blue or rapid response team activation - unmonitored patient
|
0.38%
4/1051 • Number of events 4 • During 4-month active deimplementation study period.
Systematic surveillance for PATIENTS: * Monitor for code blue /rapid response team activations in unmonitored bronchiolitis patients * Investigators determine whether the Adverse Event meets Serious Adverse Event (SAE)/unanticipated problem (UAP) criteria We did not conduct systematic assessment for Serious Adverse Events, Other (Not Including Serious) Adverse Events, code blue events, rapid response events, or all-cause mortality in STAFF SURVEYED.
|
—
0/0 • During 4-month active deimplementation study period.
Systematic surveillance for PATIENTS: * Monitor for code blue /rapid response team activations in unmonitored bronchiolitis patients * Investigators determine whether the Adverse Event meets Serious Adverse Event (SAE)/unanticipated problem (UAP) criteria We did not conduct systematic assessment for Serious Adverse Events, Other (Not Including Serious) Adverse Events, code blue events, rapid response events, or all-cause mortality in STAFF SURVEYED.
|
|
Respiratory, thoracic and mediastinal disorders
a code blue or rapid response team activation - monitored patient
|
0.10%
1/1051 • Number of events 1 • During 4-month active deimplementation study period.
Systematic surveillance for PATIENTS: * Monitor for code blue /rapid response team activations in unmonitored bronchiolitis patients * Investigators determine whether the Adverse Event meets Serious Adverse Event (SAE)/unanticipated problem (UAP) criteria We did not conduct systematic assessment for Serious Adverse Events, Other (Not Including Serious) Adverse Events, code blue events, rapid response events, or all-cause mortality in STAFF SURVEYED.
|
—
0/0 • During 4-month active deimplementation study period.
Systematic surveillance for PATIENTS: * Monitor for code blue /rapid response team activations in unmonitored bronchiolitis patients * Investigators determine whether the Adverse Event meets Serious Adverse Event (SAE)/unanticipated problem (UAP) criteria We did not conduct systematic assessment for Serious Adverse Events, Other (Not Including Serious) Adverse Events, code blue events, rapid response events, or all-cause mortality in STAFF SURVEYED.
|
Additional Information
Chris Bonafide, MD, MSCE
Children's Hospital of Philadelphia
Phone: 267-426-2901
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place